Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 1561 AL 1575

Efficacy and Safety of a Transdermal Donepezil Patch in Patients with Mild to Moderate Alzheimer's Disease: Open-Label, Extension Study

Nakamura Y, Omori T, Kim R, Nishiyama K, Kikuchi T, Ishikawa I, Aoki H.

J Alzheimers Dis. 2023;94(2):685-693. doi: 10.3233/JAD-230387.

Discerning the Prospects of miRNAs as a Multi-Target Therapeutic and Diagnostic for Alzheimer's Disease

Bhatnagar D, Ladhe S, Kumar D.

Mol Neurobiol. 2023 Oct;60(10):5954-5974. doi: 10.1007/s12035-023-03446-0. Epub 2023 Jun 29.

Passive Alzheimer's immunotherapy: A promising or uncertain option?

Høilund-Carlsen PF, Revheim ME, Costa T, Alavi A, Kepp KP, Sensi SL, Perry G, Robakis NK, Barrio JR, Vissel B.

Ageing Res Rev. 2023 Sep;90:101996. doi: 10.1016/j.arr.2023.101996. Epub 2023 Jul 5.

Therapy and diagnosis of Alzheimer's disease: from discrete metal complexes to metal-organic frameworks

García-García A, Rojas S, Rodríguez-Diéguez A.

J Mater Chem B. 2023 Aug 2;11(30):7024-7040. doi: 10.1039/d3tb00427a.

Review of triazole scaffolds for treatment and diagnosis of Alzheimer's disease

Li Q, Qi S, Liang J, Tian Y, He S, Liao Q, Xing S, Han L, Chen X.

Chem Biol Interact. 2023 Sep 1;382:110623. doi: 10.1016/j.cbi.2023.110623. Epub 2023 Jul 13.

Trial of Solanezumab in Preclinical Alzheimer's Disease

Sperling RA, Donohue MC, Raman R, Rafii MS, Johnson K, Masters CL, van Dyck CH, Iwatsubo T, Marshall GA, Yaari R, Mancini M, Holdridge KC, Case M, Sims JR, Aisen PS; A4 Study Team.

N Engl J Med. 2023 Sep 21;389(12):1096-1107. doi: 10.1056/NEJMoa2305032. Epub 2023 Jul 17.

Capturing Measures That Matter: The Potential Value of Digital Measures of Physical Behavior for Alzheimer's Disease Drug Development

Bachman SL, Blankenship JM, Busa M, Serviente C, Lyden K, Clay I.

J Alzheimers Dis. 2023;95(2):379-389. doi: 10.3233/JAD-230152.

The Sigma Receptors in Alzheimer's Disease: New Potential Targets for Diagnosis and Therapy

Wang T, Jia H.

Int J Mol Sci. 2023 Jul 27;24(15):12025. doi: 10.3390/ijms241512025.

Advanced brain imaging for the diagnosis of Alzheimer disease

Wang YT, Rosa-Neto P, Gauthier S.

Curr Opin Neurol. 2023 Oct 1;36(5):481-490. doi: 10.1097/WCO.0000000000001198. Epub 2023 Aug 3.

Current emerging novel therapies for Alzheimer's disease and the future prospects of magneto-mechanical force therapy

Shen Y, Wang M, Li S, Yang J.

J Mater Chem B. 2023 Oct 11;11(39):9404-9418. doi: 10.1039/d3tb01629c.

Advancements in the Application of Nanomedicine in Alzheimer's Disease: A Therapeutic Perspective

Puranik N, Yadav D, Song M.

Int J Mol Sci. 2023 Sep 13;24(18):14044. doi: 10.3390/ijms241814044.

The Association Between Herpes Simplex Virus and Alzheimer's Disease: A Systematic Review

Cohen M, Austin E, Bradu S, Jagdeo J.

J Drugs Dermatol. 2023 Oct 1;22(10):1046-1052. doi: 10.36849/JDD.6785.

Applications of Nanoparticles in Alzheimer's Disease

Liu Y, Shen Y.

J Alzheimers Dis. 2023;96(2):459-471. doi: 10.3233/JAD-230098.

Lecanemab Clarity AD: Quality-of-Life Results from a Randomized, Double-Blind Phase 3 Trial in Early Alzheimer's Disease

Cohen S, van Dyck CH, Gee M, Doherty T, Kanekiyo M, Dhadda S, Li D, Hersch S, Irizarry M, Kramer LD.

J Prev Alzheimers Dis. 2023;10(4):771-777. doi: 10.14283/jpad.2023.123.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias